Montel explains that he can stand up straight without pain for the first time in over 5 years. The extreme neuralgic pain (nerve pain) in his lower extremities, pain in his feet and problems with his balance that have plagued him for the past 5-6 years have begun to resolve after being adjusted using Atlas Orthogonal upper cervical techniques developed by Dr. Roy Sweat.

Friends that know him have noticed a marked change. He is walking differently, his pain is less, and he has regained strength in his leg.

Montel’s chiropractor, Dr. Patrick Kerr, explains that this is the direct result of removing pressure on the brain stem resulting from misalignment of the atlas, the top bone of the spine. Dr. Kerr explains how misalignment of the spine causes mechanical compression of the nerve roots that exit the spine, causing all kinds of dysfunction. Properly aligning the spine reestablishes proper communication between the brain and the rest of the body.

Montel explains that misalignment of the spine is frequently a result of trauma in one form or another. When the atlas vertebra is subjected to stresses and strains, it may be pushed out of proper alignment. Trauma may include car accidents (no matter how minor and regardless of immediate symptoms), slips and falls, blows to the head, or sports related injuries.

Repetitive micro traumas, such as bad sleeping habits, poor posture, incorrect lifting and carrying can also cause misalignment. In children, often the birth process itself introduces spinal misalignments.

The resulting misalignment can cause nerve pressure and inflammation causing a disruption of the normal functioning of the nervous system and interfering with the bodies’ ability to function properly, self regulate, adapt and heal.

Montel reiterates near the end of the clip, “It’s the most amazing thing that has ever happened to me!”

Tony was involved in a horrific crash at over 300mph on October 7, 2000 in Memphis Tennessee. His left leg was broken in 7 places, 6 fingers were dislocated, and he had a very serious concussion. Surgery to his leg was performed by top orthopedic trauma surgeons at the Ortho Indy Center, a facility that specializes in the treatment of racecar drivers injuries.

After the surgery, Tony was left in a constant state of pain. He was plagued by debilitating headaches and dizziness. His medical doctors could not identify the cause of his pain. He was incapacitated. Until a friend suggested he see a chiropractor.

Dr. Marshall Dickholtz performed upper cervical specific chiropractic adjustments to Tony and after several adjustments; Tony began to feel like himself again and was on his road to recovery.

"This procedure has the effect of not one, but two blood-pressure medications given in combination," study leader George Bakris, MD, tells WebMD. "And it seems to be adverse-event free. We saw no side effects and no problems," adds Bakris, director of the University of Chicago hypertension center.

Eight weeks after undergoing the procedure, 25 patients with early-stage high blood pressure had significantly lower blood pressure than 25 similar patients who underwent a sham chiropractic adjustment. Because patients can't feel the technique, they were unable to tell which group they were in.

X-rays showed that the procedure realigned the Atlas vertebra -- the doughnut-like bone at the very top of the spine -- with the spine in the treated patients, but not in the sham-treated patients.

Compared to the sham-treated patients, those who got the real procedure saw an average 14 mm Hg greater drop in systolic blood pressure (the top number in a blood pressure count), and an average 8 mm Hg greater drop in diastolic blood pressure (the bottom blood pressure number).

None of the patients took blood pressure medicine during the eight-week study.

"When the statistician brought me the data, I actually didn't believe it. It was way too good to be true," Bakris says. "The statistician said, 'I don't even believe it.' But we checked for everything, and there it was."

Bakris and colleagues report their findings in the advance online issue of the Journal of Human Hypertension.

Atlas Adjustment and Hypertension

The procedure calls for adjustment of the C-1 vertebra. It's called the Atlas vertebra because it holds up the head, just as the titan Atlas holds up the world in Greek mythology. Marshall Dickholtz Sr., DC, of the Chiropractic Health Center, in Chicago, is the 84-year-old chiropractor who performed all the procedures in the study. He calls the Atlas vertebra "the fuse box to the body."

"At the base of the brain are two centers that control all the muscles of the body. If you pinch the base of the brain -- if the Atlas gets locked in a position as little as a half a millimeter out of line -- it doesn't cause any pain but it upsets these centers," Dickholtz tells WebMD.

The subtle adjustment is practiced by the very small subgroup of chiropractors certified in National Upper Cervical Chiropractic (NUCCA) techniques. The procedure employs precise measurements to determine a patient's Atlas vertebra alignment. If realignment is deemed necessary, the chiropractor uses his or her hands to gently manipulate the vertebra.

"We are not doctors. We are spinal engineers," Dickholtz says. "We use mathematics, geometry, and physics to learn how to slide everything back into place."

What does this have to do with high blood pressure?

Bakris notes that some researchers have suggested that injury to the Atlas vertebra can affect blood flow in the arteries at the base of the skull. Dickholtz thinks the misaligned Atlas triggers release of signals that make the arteries contract. Whether the procedure actually fixes such injuries is unknown, Bakris says.

Bakris began the study after a fellow doctor told him that something strange was happening in his family practice. The doctor had been sending some of his patients to a chiropractor. Some of these patients had high blood pressure.

Yet after seeing the chiropractor, the patients' blood pressure had normalized -- and a few of them were able to stop taking their blood pressure medications.

So Bakris, then at Rush University, designed the pilot study with 50 patients. He's now organizing a much bigger clinical trial.

"Is it going to be for everybody with high blood pressure? No," Bakris says. "We clearly need to identify those who can benefit. It is pretty clear that some kind of head or neck trauma early in life is related to this. This is really a work in progress. It is certainly in the early stages of research."

Dickholtz has been teaching, practicing, and studying the NUCCA technique for 50 years. He says high blood pressure is far from the only thing an Atlas misalignment causes.

"On the other hand, if people have high blood pressure, there is a tremendous possibility they need an Atlas adjustment," he says.

When his mother first brought him to the chiropractor, he was only having a very painful bowel movement every 1-2 weeks. His doctors were never able to diagnose a cause for the problem and had treated him with laxatives, lots of fluid and fiber, none of which worked.

His chiropractor examined him and found out his sacrum, the large triangular bone at the bottom of the spine, was subluxated (out of its normal position). Adjustments were given and the results were almost immediate. His mother reported that he had a bowel movement that first day and then another one two days later. She was excited and said this had never happened before.

Care continued for another four weeks and he continued to improve to the point he was experiencing completely normal bowel function. Indeed, a follow up phone call 13 years later found he was still regular.

Previous research has indicated that 3% of kids’ visits to their family doctors and 30% of those to pediatric gastroenterologists are for chronic constipation. The usual treatments, which failed in this case, normally fail in up to half of the kids treated.

The topics mentioned included birth control, abortion and sedating dying patients. 29% of the doctors also said they felt no obligation to tell patients where they can go to get that care.

Lead author Dr. Farr Curlin of the University of Chicago said, “If physicians’ ideas translate into their practices, then 14 percent of patients – more than 40 million Americans – may be cared for by physicians who do not believe they are obligated to disclose information about medically available treatments they consider objectionable.”

“In addition, 29 percent of patients – or nearly 100 million Americans – may be cared for by physicians who do not believe they have an obligation to refer the patient to another provider for such treatments.”

In this review, the author reviewed eight studies and discussed the various theories of how these disorders develop, the neurological dysfunctions involved and how chiropractic care may help.

There were two models (theories) that explain how vertebral subluxations (misalignments of the small bones of the spine and related structures) can contribute to the problem as well as how adjusting them can help restore normal function.

The first one is called the hemisphericity model. It proposes that altered spinal mechanics and subluxations reduce the quantity and quality of signals entering the brain through the nervous system. This can ultimately result in an unbalanced lack of communication between the two halves of the brain that is integral to the learning process.

The neurologic disorganization model says that various body malfunctions, including vertebral subluxations, can lead to functional disturbances in the higher centers of the central nervous system, resulting in learning disabilities and dyslexia.

Recent research showing that chiropractic care helps improved cognitive brain function supports both models.

The author goes on to point out that in the research he reviewed the chiropractor was not as interested in treating the learning disabilities and dyslexia as much as correcting the underlying nervous system malfunctions that underlie the disorders. By removing subluxation interference and improving the brain functions important in learning skills, chiropractic was able to directly or indirectly address deficits related to learning disabilities and dyslexia.

The report concludes that while the research evidence so far has to be considered preliminary, “there seems to be a potential role for chiropractic care to improve various [brain functions] known to be essential in learning. Further research in this important area of health care is greatly needed.”

SOURCE: New York Times, January 2, 2007

As reported in other chiropractic journals such as Chiropractic Technique and the Chiropractic Research Journal, numerous case studies as far back as 1989 have shown that patients with diabetes improve under chiropractic care.

The patient in this case was a 48 year-old man whose medical doctor had diagnosed him with early onset diabetes mellitus. Wishing to take a non-medical approach with the goal of avoiding insulin injections, he consulted a chiropractor. After his spine was analyzed and vertebral subluxations were found, he decided to begin a course of chiropractic care to help normalize body balance and function.

He also consulted a doctor of oriental medicine who suggested he begin other wellness approaches such as nutritional supplements and exercise along with acupuncture.

After a month of care, the patient experienced improvement in the chiropractic indicators of subluxation. At the same time, his blood and urine sugar levels returned to normal. Throughout the process, his diabetic symptoms were monitored by the medical and oriental doctors who determined that he would not need insulin as long as his condition maintained itself.

The author points out that it is not clear that chiropractic itself was responsible for the health improvements the patient experienced. He goes on to say, however, that if “chiropractic care can offer assistance in treatment of 5% of the diabetic conditions commonly presented to health care providers this alone could offer significant life style enhancement for those patients positively influenced.”

Preliminary results from a long-term clinical trial (up to three years) suggest that long term use of a non-selective NSAID, naproxen (sold as Aleve, Naprosyn and other trade name and generic products), may be associated with an increased cardiovascular (CV) risk compared to placebo.

While the results of these studies are preliminary and conflict with other study data on the same drugs, FDA is providing this advisory as an interim measure, pending further review of data that continue to be collected. Specifically:

• Physicians prescribing Celebrex (celecoxib) or Bextra (valdecoxib), should consider this emerging information when weighing the benefits against risks for individual patients. Patients who are at a high risk of gastrointestinal (GI) bleeding, have a history of intolerance to non-selective NSAIDs, or are not doing well on non-selective NSAIDs may be appropriate candidates for COX-2 selective agents.
• 
  
• Individual patient risk for cardiovascular events and other risks commonly associated with NSAIDs should be taken into account for each prescribing situation.
• 
  
• Consumers are advised that all over-the-counter (OTC) pain medications, including NSAIDs, should be used in strict accordance with the label directions. If use of an OTC NSAID is needed for longer than ten days, a physician should be consulted.

Non-selective NSAIDs are widely used in both over-the-counter (OTC) and prescription settings. As prescription drugs, many are approved for short-term use in the treatment of pain and primary dysmenorrhea (menstrual discomfort), and for longer-term use to treat the signs and symptoms of osteoarthritis and rheumatoid arthritis. FDA has previously posted extensive NSAID medication information at http://www.fda.gov/cder/drug/analgesics/default.htm.

FDA will be analyzing all available information from the new studies of Vioxx, Celebrex, Bextra, and naproxen, and other data for non-selective NSAIDs and COX-2 selective products to determine whether additional regulatory action is needed. An advisory committee meeting is planned for February 2005 which will provide for a full discussion of these issues.

The study’s key findings centered upon how omega-3 fatty acids and lutein with zeaxanthin allow seniors to avoid common conditions such as coronary heart disease (CHD) and age-related macular degeneration (AMD). The supplements help them live independently longer and reduce the level of disability associated with these conditions.

The Food and Drug Administration (FDA) has issued a qualified health claim for omega-3 fatty acids and a qualified health claim is currently pending for lutein.

According to Ray Fowler, MD, deputy EMS medical director for the Dallas area, “The work of Rebecca Burton, DC, [a Dallas-area practitioner] and her team was a critical part of the infrastructure to make the operation run. We would not have operated as efficiently and volunteers would not have had as much support as they needed without the chiropractors and the rehab clinic. This was a blessing.”

Burton’s team largely came about because of the involvement of Zonsite LLC, the marketing technology company that championed getting donations from chiropractic suppliers and rallied volunteer support among chiropractors around the state.

When Fowler asked Burton to head up the emergency rehab unit, she called Daniel Gonzalez, DC, her partner in OneHealth Chiropractic Clinic and Zonsite’s president and chief scientist, for help in gathering chiropractic resources.

The Dallas Convention Center Medical Unit provided care to more than 3,000 urgent cases, 3,300 routine cases, 711 pediatric cases, 138 obstetrics/gynecology cases, and 461 mental health cases. On average, the medical staff saw 615 patients each day, according to Fowler. The unit operated for three weeks following Katrina.

The rehab unit Burton set up was manned by about 100 chiropractors who worked in 14-16 hour shifts.

Although an emergency medical plan was in effect for Dallas, chiropractic was not officially a part of the plan, said Fowler. He wants to rectify that, and so do the principals at Zonsite. Chris Russell, CEO of Zonsite, said, “We have an opportunity to proliferate chiropractic within Homeland Security … to have a disaster-relief team attached to government.”

Russell is hoping to get the chiropractic community involved in a formal emergency-relief program. He wants to meet with interested personnel at the Parker Seminars in Las Vegas in January. He emphasized that it takes considerable organization to be ready to respond when needed.

He said, “In a disaster zone, it is hours, not days, that count.” Russell expressed gratitude for the help that came from suppliers and chiropractors.

A start toward including chiropractic in EMS will be made in the Dallas area. Fowler said, “As we craft our after-action reports for this episode [Hurricanes Katrina and Rita], we will focus on the important part of setting up a rehab area. Chiropractic should be involved in long-term planning for emergency response. They [chiropractors] proved how valuable chiropractic could be.”

Fowler, who works full-time as an associate professor of emergency medicine and surgery at the University of Texas Southwestern School of Medicine, said that emergency responders from all over will be comparing notes and recommendations, so he expects to see chiropractic incorporated into other EMS plans.

In addition to Zonsite, who had three staffers at the emergency rehab clinic helping coordinate resources, Russell credited other chiropractic suppliers, which included Anabolic Labs, BioGenesis, BioResource, BioFreeze, DaVinci Labs, Lloyd Table Co., King Bio, Hill Country Manufacturing, HCMI, Vita Minerals, and Wren Chiropractic.

Sources: Ray Fowler, MD, deputy EMS medical director for the Dallas Area BioTel System; Chris Russell, CEO, Zonsite LLC

The study by leading heart researchers found twice as many deaths and cardiovascular problems in diabetic adults taking the drug Pargluva as those on dummy pills or a competing drug.

Developed by Bristol-Myers Squibb and Merck & Co., the drug, known generically as muraglitazar, was endorsed by a Food and Drug Administration panel last month. It is a treatment for Type 2 diabetes, the most common form of the condition and one that occurs most often in people who are overweight.

The Journal of the American Medical Association said it posted the analysis on its Web site Thursday ahead of next month's publication date because of public safety concerns. The study was by Cleveland Clinic doctors who reviewed data the FDA made public before the panel vote.

If the analysis is correct, the drug could have meant a "public health catastrophe" given that 18 million Americans have diabetes, said Dr. Steven Nissen, who worked on the analysis with Dr. Eric Topol and a clinic statistician.

"This is the Vioxx that isn't going to happen," Nissen said, referring to the popular painkiller Merck removed from the market last year after it was linked with serious heart problems. Nissen has done consulting work for several drug companies, including Merck and makers of other diabetes treatments, but said he does not accept fees for that work.

Critics including Nissen have accused the FDA of lax drug surveillance because of Vioxx and other recent safety issues, such as evidence linking some antidepressants with a greater risk of suicidal thoughts in youngsters.

The FDA appeared to be heading down the same road with Pargluva despite that criticism, said Dr. Catherine DeAngelis, JAMA's editor in chief.

"It is beyond me why individuals who are supposed to be overseeing the safety of the public would take a chance when it's not necessary," DeAngelis said.

In a statement, the FDA said it appreciates "the need for careful assessment of risk versus benefit for all drugs, particularly those indicated for long-term, preventive therapy."

"The FDA has made significant investments of resources and expertise in developing fundamentally better methods for identifying and monitoring cardiovascular safety issues with all drugs."

Bristol-Myers Squibb and Merck issued a written statement Thursday that said Pargluva "was extensively studied and all available data were reported to the FDA."

Pargluva would be the first diabetes drug on the market designed to lower blood sugar, reduce fatty triglycerides and increase levels of "good" cholesterol, Nissen said. Other drugs achieve those results individually, said Dr. Peter Lurie, deputy director of the Public Citizen Health Research Group, a consumer advocacy group.

The analyzed data involved 3,725 patients who took Pargluva or a drug called pioglitazone or dummy pills in different studies lasting from 24 weeks to 104 weeks.

Deaths, heart attacks or strokes occurred in 35 of the 2,374 Pargluva patients versus nine of 1,351 patients in a combined group on the other drug or on dummy pills. Increased risks for mini-strokes and heart failure also were found among Pargluva patients.

A JAMA editorial notes that the new analysis contrasts sharply with data company sponsors presented to the FDA showing no significant excess risk of death or cardiovascular problems.

Company-provided data might have fostered an "illusion of safety" because of numerous omissions, such as excluding patients most likely to face cardiovascular risks, including elderly diabetics, said editorial author Dr. James Brophy of McGill University.

The drug had been projected to bring the companies $1 billion yearly, and DeAngelis contended that money appeared to trump safety.

Pargluva's makers said earlier this week they had received a letter from the FDA that indicated the drug was "approvable" but which also asked for more safety data on the drug's cardiovascular effects.

Nissen said final FDA action had been expected next week. The agency often follows recommendations from its advisory panels.

It's uncertain how quickly the companies can produce the data FDA wants, but the new analysis now puts approval in doubt, said Lurie, the official with Public Citizen, which had presented similar safety concerns to the FDA panel.

"An article by two such prominent cardiologists could be the nail in the coffin for this drug," he said. "It's going to make it much more difficult for (the FDA) to look at whatever data the companies submit and conclude that the drug should be approved."

Even without the JAMA article, the drug likely would not have hit the market for at least several months, Lurie said.

In their written statement Thursday, Bristol-Myers Squibb and Merck said that after receiving the FDA's letter requesting more data, they were "eager to begin discussions with the FDA to address more fully the cardiovascular safety profile of the compound and to determine what additional information may be necessary."

Back in Jan 2002, again without a peep of media, a new niche was tacked onto the Mandated Schedule: the High Risk category. Hard on the heels of 9/11, CDC said that vaccines in this new category would be for those with a propensity for colds and flu or for anyone else wishing to obtain immunity for the proscribed diseases. They opened with 2 vaccines: influenza and Hepatitis A.

By serendipitous synchronicity, the medical journal Pediatrics that same month carried an article written by an FDA Advisory Board member, Paul Offit: Do Vaccines Overwhelm the Immune System? The article had a strange non-professional persuasive essay tone to it, almost as though it were written for parents rather than for the usual readers of a scientific journal. And it told us, yes, yes we know that it must seem like kids are getting a lot of vaccines these days. In this article we will estimate the total number of vaccines to which a child could respond to at any one time. The study's conclusion: each infant would have the theoretical capacity to respond to about 10,000 vaccines at any one time. This was not Mad magazine, nor a script for Saturday Night Live. This was a peer-reviewed medical journal.

The timing was obvious: 4 months post 9/11. This was the beginning of that year and a half when we were daily terrorized with the threat of being forced to submit to mass smallpox vaccination, remember? Amazing that after spending $3 billion of your money stockpiling enough smallpox vaccines for every American, it was then discovered that the vaccine was too dangerous, and the program was scrapped by Oct 2003. A little research here shows that the program was never about anything other than the $3 billion.
Excerpted from The Sanctity of Human Blood: Vaccination is Not Immunization by Tim O'Shea

Texas Algorithm grossed over 4 billion dollars in 2003 and olanzapine is Eli Lilly's top-selling drug. A 2003 New York Times article by Gardiner Harris claims that 70 percent of olanzapine sales are paid for by government agencies, such as Medicare and Medicaid. And lo and behold, guess who is now able to bill Medicaid for health services? Public schools, of course, as they are now under the big pharma-political profits/pay-back umbrella once they adopt screening policies. Public schools can now be paid to screen and drug your kids.

Now, if you ever wonder, ever again, if public-private partnerships care about people, then you need a brain transplant. Your children are now the legislated guinea pigs and lab rats for the pharmaceutical companies who bought and paid for our president's campaign. Favors are now returned to those companies in the form of enforced juvenile customers, their health, and their future drug addictions.

But wait, there is more. The New Freedom Commission also calls for enforced treatment. That means that parents have no rights to refuse the treatment recommenced by TMAP and other drug dispensing corporate-bureaucratic apparatuses. And as the mental health bureaucracy is also involved in this financial game of insidious cruelty, parents and families are also to be investigated via the result of their children's screenings in schools. In other words, schools are now the across-the-board, or shall I say -nation, diagnostic tool for big pharma and child control.

And there's more. The U.N. Agenda 21 has also called for total intrusion into schools and children's lives. No more religion, no more individuality, no more real education, no more real grades, no more real teaching, no more teacher respect for parents, and no more truth from teachers or principals. This sounds very familiar and very political to me. And I've said it before, and I will say it again: if you are of a religious ilk and you refuse to allow your children to be abused by our "educational" system, the stage is being set for you to lose physical custody of your children. I suggest that you read this: 'Rethinking Orphanages for the 21st Century' by Richard McKenzie.

Per Zeus Information Service
Alternative Views on Health